1-5 of 5
Shaker Dakhil, MD
Close
Sort by
Journal Articles

Continued Excellent Outcomes in Previously Untreated Follicular Lymphoma Patients after Treatment with CHOP Plus Rituximab or CHOP Plus (131) Iodine-Tositumomab - Long Term Follow-up of Phase III Randomized Study SWOG S0016

Mazyar Shadman, MD MPH, Hongli Li, PhD, Lisa Rimsza, MD, John P. Leonard, MD, Mark S Kaminski, MD, Rita M Braziel, MD, Catherine M. Spier, MD, Ajay K Gopal, MD, David G Maloney, MD PhD, Bruce Cheson, MD, Shaker Dakhil, MD FACP, Michael LeBlanc, PhD, Sonali M. Smith, MD, Richard I. Fisher, MD, Jonathan W. Friedberg, MD, Oliver Press, MD PhD
Journal: Blood
Blood (2016) 128 (22): 616.
https://doi.org/10.1182/blood.V128.22.616.616
Published: 2016
Journal Articles

ENESTnext Final Results: Deep Molecular Response (MR) with Nilotinib (NIL) in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Jesus G. Berdeja, MD, Michael Heinrich, Shaker Dakhil, MD FACP, Stuart L. Goldberg, MD, Martha Wadleigh, MD, Rosalind Catchatourian, MD, Philip Kuriakose, MD, Jorge E. Cortes, MD, Jerald P. Radich, David A. Rizzieri, MD, Gaetano Bonifacio, MD, Ilva Dautaj, Ghulam Warsi, PhD, Michael J. Mauro, MD
Journal: Blood
Blood (2015) 126 (23): 4048.
https://doi.org/10.1182/blood.V126.23.4048.4048
Published: 2015
Journal Articles

Effect of Age on Efficacy and Safety Outcomes in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Receiving Lenalidomide and Low-Dose Dexamethasone (Rd): The First Trial

Cyrille Hulin, MD, Thierry Facon, MD, Chaim Shustik, MD, Andrew Belch, MD, Maria Teresa Petrucci, MD, Ulrich Dührsen, MD, Jin Lu, MD, Kevin Song, MD, Philippe Rodon, Brigitte Pegourie, MD, Laurent Garderet, MD, Hannah Hunter, Isabelle Azais, MD, Richard Eek, MD, Margaret Macro, MD, Shaker Dakhil, MD FACP, Vanessa Houck, Guang Chen, Annette Ervin-Haynes, Fritz Offner, MD
Journal: Blood
Blood (2014) 124 (21): 81.
https://doi.org/10.1182/blood.V124.21.81.81
Published: 2014
Journal Articles

Deep Molecular Response in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib: ENESTnext Update

Michael J. Mauro, MD, Shaker Dakhil, MD FACP, Jorge E. Cortes, MD, David A. Rizzieri, MD, Christopher H Keir, MD, Sandy Yi, MS, Michael C. Heinrich, MD, Stuart L. Goldberg, MD, Rosalind Catchatourian, MD, Philip Kuriakose, MD, Jerald P Radich, MD
Journal: Blood
Blood (2014) 124 (21): 1796.
https://doi.org/10.1182/blood.V124.21.1796.1796
Published: 2014
Journal Articles

Single-Arm, Open-Label, Multicenter Study Of Deep Molecular Response (MR 4.5 ) With Nilotinib In Adult Patients (pts) With Newly Diagnosed Philadelphia Chromosome–Positive Chronic Myeloid Leukemia In Chronic Phase (CML-CP): ENESTnext Study Update

Michael Mauro, MD, Jerald Radich, MD, Jorge E. Cortes, MD, Shaker Dakhil, MD, Christopher Keir, MD, Sandy Yi, Martha Wadleigh, MD, Vivian G. Oehler, MD, Thomas Ervin, MD, Stuart Goldberg, MD, Michael Savona, MD, FACP
Journal: Blood
Blood (2013) 122 (21): 4015.
https://doi.org/10.1182/blood.V122.21.4015.4015
Published: 2013